DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Zota Health Care LImited — Board Meeting Intimation

NSE 4 hrs ago·6 Aug 2026, 12:56 pm

Zota Health Care

Zota Healthcare has announced a board meeting scheduled for August 13, 2026. The primary agenda for this meeting is to review and approve the company's unaudited quarterly financial results for the period ending June 2026. This is a routine corporate action where the board assesses the firm's performance over the last quarter.

For investors, this announcement is a key milestone as it signals that the company is nearing the release of its latest performance data. The results will provide a snapshot of the company's operational health and financial trajectory in the interim period. Market participants will closely watch the figures to gauge the company's growth momentum.

Investors should wait for the official disclosure of the financial results to understand the company's current standing. The data will help in evaluating the company's operational efficiency and future outlook, allowing investors to make informed decisions based on the latest available information.